Arrowhead Pharmaceuticals (ARWR) Net Margin Growth (1y) (2011 - 2026)
Arrowhead Pharmaceuticals (ARWR) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,491.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -25,435.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25,435.00 |
| Dec 31, 2025 | 701,942.00 |
| Dec 31, 2024 | -319,639.00 |
| Dec 31, 2023 | -374,551.00 |
| Sep 30, 2023 | -41,748.00 |
| Jun 30, 2023 | -43,570.00 |
| Mar 31, 2023 | 337.00 |
| Dec 31, 2022 | 16,231.00 |
| Sep 30, 2022 | -10,664.00 |
| Jun 30, 2022 | -15,708.00 |
| Mar 31, 2022 | 11,096.00 |
| Dec 31, 2021 | -13,181.00 |
| Sep 30, 2021 | 46,897.00 |
| Jun 30, 2021 | -1,549.00 |
| Mar 31, 2021 | 257.00 |
| Dec 31, 2020 | -8,824.00 |
| Sep 30, 2020 | -40,677.00 |
| Jun 30, 2020 | -9,455.00 |
| Mar 31, 2020 | -12,770.00 |
| Dec 31, 2019 | -4,381.00 |